Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][4]. Company Overview - Ardent Health operates acute care hospitals and healthcare facilities, with a focus on the collection of accounts receivable [5]. Allegations - The lawsuit claims that Ardent Health misrepresented its collection practices, stating it relied on "detailed reviews of historical collections" when, in fact, it used a "180-day cliff" method for determining account collectability, leading to inflated accounts receivable figures [5]. - The alleged misrepresentations are said to violate federal securities laws [5]. Stock Performance - On November 12, 2025, Ardent Health announced a $43 million revenue decrease and a $54 million increase in professional liability reserves, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [6][9]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the case caption Postiwala v. Ardent Health, Inc., et al. [4][9].
ARDT Deadline: BFA Law Urges Ardent Health Investors with Losses to Act Before March 9 Securities Fraud Class Action Deadline Amid 33% Stock Decline